Magnetic resonance/transrectal ultrasound fusion biopsy of the prostate compared to systematic 12-core biopsy for the diagnosis and characterization of prostate cancer: multi-institutional retrospective analysis of 389 patients
详细信息 查看全文
- 作者：Guilherme C. Mariotti ; M.D.a ; Daniel N. Costa ; M.D.b ; Daniel.Costa@UTSouthwestern.edu" class="auth_mail" title="E-mail the corresponding author ; Ivan Pedrosa ; M.D.b ; Priscila M. Falsarella ; M.D.a ; Tatiana Martins ; M.D.c ; Claus G. Roehrborn ; M.D.d ; Neil M. Rofsky ; M.D.b ; Yin Xi ; M.D.b ; Thais C. M. Andrade ; M.D.c ; Marcos R. Queiroz ; M.D.a ; Yair Lotan ; M.D.d ; Rodrigo G. Garcia ; M.D.a ; Gustavo C. Lemos ; M.D.e ; Ronaldo H. Baroni ; M.D. ; Ph.D.c
- 关键词：Early detection of cancer ; Risk assessment ; Prostatic Neoplasms ; Biopsy ; Magnetic Resonance Imaging
- 刊名：Urologic Oncology: Seminars and Original Investigations
- 出版年：2016
- 出版时间：September 2016
- 年：2016
- 卷：34
- 期：9
- 页码：416.e9-416.e14
- 全文大小：419 K
文摘
- •
Targeted biopsy detects more intermediate-to-high-risk PCa than systematic biopsy
- •
Targeted biopsy detects fewer low-risk PCa than systematic biopsy
- •
Results are achieved in biopsy-naïve men and in patients with previous negative biopsies
- •
Results are reproduced with diverse imaging protocols, biopsy devices, and operators